Investor Presentation

62 Investor presentation First six months of 2022 Global obesity market growth has been accelerating with Novo Nordisk capturing the majority of growth 80% 60% 40% 20% Obesity market growth and Novo Nordisk value market share Obesity market size and growth DKK billion 84% 180% 155% ~111% 20.0 0.3 140% 111% 10.3 100% 9.5 60% ~155% 84% 0% 20% 70% -20% -20% May May May NN Obesity care Others 2019 -NN market share 2022 2021 -Market growth (right axis) Obesity NN Growth (right axis) Source: IQVIA, May 2022 Value MAT, all countries; Share of growth not depicted due to high growth May 2022 Others Novo NordiskⓇ

View entire presentation